You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 3
  • #78 Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) are associated with adverse overall survival outcomes in patients who receive radical radiotherapy for locally advanced vulvar cancer

Article info

Article menu

Download PDFPDF

Poster/ePoster Sessions
13. Vaginal and Vulvar Cancer
#78 Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) are associated with adverse overall survival outcomes in patients who receive radical radiotherapy for locally advanced vulvar cancer
Free

Authors

Citation

Grech J, Mcloone P, Sadozye A, et al
#78 Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) are associated with adverse overall survival outcomes in patients who receive radical radiotherapy for locally advanced vulvar cancer
International Journal of Gynecologic Cancer 2023;33:A377-A378.

Publication history

  • First published September 27, 2023.
Online issue publication 
September 28, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.